Global Antifungal Agents Market Size, by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), by Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis), & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1012240
  • |
  • Publishe Date : May 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Antifungal Agents market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increase in the prevalence of fungal infections such as aspergillosis and candidiasis, patients suffering from hospital-acquired infections are factors supplementing the antifungal agents market globally. However, presence of counterfeit drugs and resistance toward antifungal drugs are some of the major factors impeding the growth of the market.

The global antifungal agents market is primarily segmented based on different drug type, therapeutic indications, and regions.

On the basis of drug type, the market is split into:
* Echinocandins
* Azoles
* Polyenes
* Allylamines

On the basis of therapeutic indications, the market is split into:
* Aspergillosis
* Dermatophytosis
* Candidiasis
* Other Indications

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Pfizer Inc.
* Sanofi S.A.
* Gilead Sciences, Inc.
* Merck & Co., Inc.
* Novartis International AG
* Abbott Laboratories
* Bayer AG
* Scynexis Inc.
* Enzon Pharmaceuticals, Inc.
* GlaxoSmithKline Plc.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, drug type, and therapeutic indications market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, drug type, and therapeutic indications with qualitative and quantitative information and facts

Target Audience:
* Antifungal Drugs Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Antifungal Agents Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Antifungal Agents Market - Porter\'s Five Forces Analysis
4.4. Global Antifungal Agents Market - PESTEL Analysis

5. Global Antifungal Agents Market, by Drug Type
5.1. Global Antifungal Agents Market, Size and Forecast, 2015-2026
5.2. Global Antifungal Agents Market, by Echinocandins, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Antifungal Agents Market, by Azoles, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Antifungal Agents Market, by Polyenes, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Antifungal Agents Market, by Allylamines, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026

6. Global Antifungal Agents Market, by Therapeutic Indications
6.1. Global Antifungal Agents Market, Size and Forecast, 2015-2026
6.2. Global Antifungal Agents Market, by Aspergillosis, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Antifungal Agents Market, by Dermatophytosis, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Antifungal Agents Market, by Candidiasis, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Antifungal Agents Market, by Other Indications, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Antifungal Agents Market, by Region
7.1. Antifungal Agents Market Regional Analysis, 2015-2026
7.2. Global Antifungal Agents Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Antifungal Agents Market, 2015-2026
7.3.1. North America Antifungal Agents Market Size and Forecast, 2015-2026
7.3.2. North America Antifungal Agents Market by Country, 2015-2026
7.3.2.1. U.S. Antifungal Agents Market, 2015-2026
7.3.2.2. Canada Antifungal Agents Market, 2015-2026
7.4. Europe Antifungal Agents Market, 2015-2026
7.4.1. Europe Antifungal Agents Market Size and Forecast, 2015-2026
7.4.2. Europe Antifungal Agents Market by Country, 2015-2026
7.4.2.1. Germany Antifungal Agents Market, 2015-2026
7.4.2.2. France Antifungal Agents Market, 2015-2026
7.4.2.3. Italy Antifungal Agents Market, 2015-2026
7.4.2.4. UK Antifungal Agents Market, 2015-2026
7.4.2.5. Spain Antifungal Agents Market, 2015-2026
7.4.2.6. Rest of Europe Antifungal Agents Market, 2015-2026
7.5. Asia Pacific Antifungal Agents Market, 2015-2026
7.5.1. Asia Pacific Antifungal Agents Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Antifungal Agents Market by Country, 2015-2026
7.5.2.1. Japan Antifungal Agents Market, 2015-2026
7.5.2.2. China Antifungal Agents Market, 2015-2026
7.5.2.3. India Antifungal Agents Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Antifungal Agents Market, 2015-2026
7.6. South America Antifungal Agents Market, 2015-2026
7.6.1. South America Antifungal Agents Market Size and Forecast, 2015-2026
7.6.2. South America Antifungal Agents Market by Country, 2015-2026
7.6.2.1. Mexico Antifungal Agents Market, 2015-2026
7.6.2.2. Brazil Antifungal Agents Market, 2015-2026
7.6.2.3. Rest of South America Antifungal Agents Market, 2015-2026
7.7. Middle East & Africa Antifungal Agents Market, 2015-2026
7.7.1. Middle East & Africa Antifungal Agents Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Antifungal Agents Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Antifungal Agents Market, 2015-2026
7.7.2.2. South Africa Antifungal Agents Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Antifungal Agents Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2019

9. Company Profiles
9.1. Pfizer Inc.
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Sanofi S.A.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Gilead Sciences, Inc.
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Merck & Co., Inc.
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Novartis International AG
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Abbott Laboratories
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Bayer AG
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Scynexis Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Enzon Pharmaceuticals, Inc.
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. GlaxoSmithKline Plc.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights





Content are not available

Choose License Type